Perkins Capital Management
WAYZATA, MNfiles as PERKINS CAPITAL MANAGEMENT INC
$133m in 79 US stocks at the end of 30 June 2026. The top 10 are 52.2% of the money. It changed about 19.1% of the portfolio this quarter.
Value
$133m
Stocks
79
Top 10 share
52.2%
Turnover
19.1%
What changed this quarter
New
Bought for the first time this quarter.
- Creative RealitiesCREX0.9% of the fund
- Neuroone Medical TechnologiesNMTC0.6% of the fund
- VIDA GlobalVIDA0.5% of the fund
- QT Imaging HoldingsQTI0.3% of the fund
- Perspective TherapeuticsCATX<0.1% of the fund
Added
Bought more of a stock they already held.
- Perion NetworkPERI1.2% of the fund+5%
- CrexendoCXDO1.2% of the fund+9%
- TriSalus Life SciencesTLSI0.8% of the fund+2%
- Castle BiosciencesCSTL0.3% of the fund+5%
- Puma BiotechnologyPBYI<0.1% of the fund+7%
- IridexIRIX<0.1% of the fund+28%
Cut
Sold some of their stake.
- NateraNTRA8.3% of the fund-8%
- Advanced Micro DevicesAMD6.1% of the fund-10%
- Butterfly NetworkBFLY5.5% of the fund-7%
- AxogenAXGN5.1% of the fund-12%
- InuvoINUV4.9% of the fund-12%
- QuicklogicQUIK3.9% of the fund-16%
- BackblazeBLZE3.7% of the fund-9%
- MicrosoftMSFT3.1% of the fund-2%
- VeracyteVCYT2.6% of the fund-20%
- OomaOOMA2.6% of the fund-2%
- MagniteMGNI1.4% of the fund-17%
- NeogenomicsNEO1.2% of the fund-17%
- TELA BioTELA0.8% of the fund-3%
- MerckMRK0.7% of the fund-3%
- PfizerPFE0.6% of the fund-6%
- TargetTGT0.5% of the fund-3%
- MDxHealth SAMDXH0.4% of the fund-4%
- Seagate Technology HoldingsSTX0.4% of the fund-5%
- AtriCureATRC0.4% of the fund-33%
- ConocoPhillipsCOP0.4% of the fund-4%
- NXP SemiconductorsNXPI0.4% of the fund-6%
- CelcuityCELC0.4% of the fund-17%
- General MillsGIS0.3% of the fund-6%
- SkyWater TechnologySKYT0.3% of the fund-55%
- Bristol-Myers SquibbBMY0.3% of the fund-3%
Sold out
Sold their entire stake.
- InogenINGN-100%
- Neuroone MED Technologies Corp.com-100%
- CPS TechnologiesCPSH-100%
- ANI PharmaceuticalsANIP-100%
- EplusPLUS-100%
- Digi InternationalDGII-100%
- VericelVCEL-100%
- VeritoneVERI-100%
- Biolife SolutionsBLFS-100%
- ExxonMobil HoldingsXOM-100%
- Asure SoftwareASUR-100%
- Rockwell MED-100%
Holdings
- VIDA GlobalVIDA
- Share
- 0.5%
- Value
- $700,000
- Shares
- 250,000
New
- SkyWater TechnologySKYT
- Share
- 0.3%
- Value
- $414,358
- Shares
- 11,900
-55%
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| NateraNTRA | 8.3% | $11m | 40,605 | -8% |
| Eli LillyLLY | 7.8% | $10m | 8,680 | Held |
| Advanced Micro DevicesAMD | 6.1% | $8m | 13,904 | -10% |
| Butterfly NetworkBFLY | 5.5% | $7m | 867,580 | -7% |
| AxogenAXGN | 5.1% | $7m | 147,842 | -12% |
| InuvoINUV | 4.9% | $6m | 515,011 | -12% |
| QuicklogicQUIK | 3.9% | $5m | 257,621 | -16% |
| Idexx LaboratoriesIDXX | 3.8% | $5m | 9,700 | Held |
| BackblazeBLZE | 3.7% | $5m | 308,725 | -9% |
| MicrosoftMSFT | 3.1% | $4m | 11,173 | -2% |
| VeracyteVCYT | 2.6% | $4m | 59,958 | -20% |
| OomaOOMA | 2.6% | $3m | 176,970 | -2% |
| PersonalisPSNL | 2.4% | $3m | 239,000 | Held |
| CryoportCYRX | 2.4% | $3m | 199,897 | Held |
| CienaCIEN | 2.3% | $3m | 6,300 | Held |
| Lemaitre VascularLMAT | 1.8% | $2m | 25,345 | Held |
| MagniteMGNI | 1.4% | $2m | 98,625 | -17% |
| Abbott LaboratoriesABT | 1.4% | $2m | 20,257 | Held |
| UsioUSIO | 1.3% | $2m | 700,371 | Held |
| OndasONDS | 1.2% | $2m | 201,483 | Held |
| NeogenomicsNEO | 1.2% | $2m | 110,040 | -17% |
| Perion NetworkPERI | 1.2% | $2m | 165,215 | +5% |
| NeogenNEOG | 1.2% | $2m | 177,500 | Held |
| CrexendoCXDO | 1.2% | $2m | 212,825 | +9% |
| Alphatec HoldingsATEC | 1.1% | $2m | 175,197 | Held |
| AbbVieABBV | 1.0% | $1m | 5,307 | Held |
| Creative RealitiesCREX | 0.9% | $1m | 300,050 | New |
| Lucid DiagnosticsLUCD | 0.9% | $1m | 1,125,000 | Held |
| CodexisCDXS | 0.9% | $1m | 526,100 | Held |
| Zeta Global HoldingsZETA | 0.8% | $1m | 55,900 | Held |
| TriSalus Life SciencesTLSI | 0.8% | $1m | 235,101 | +2% |
| TELA BioTELA | 0.8% | $1m | 1,375,042 | -3% |
| BiodesixBDSX | 0.8% | $1m | 44,618 | Held |
| Safe Pro GroupSPAI | 0.8% | $998,065 | 230,500 | Held |
| MerckMRK | 0.7% | $963,750 | 7,500 | -3% |
| Gilead SciencesGILD | 0.7% | $911,669 | 7,216 | Held |
| ViatrisVTRS | 0.6% | $854,932 | 53,837 | Held |
| PfizerPFE | 0.6% | $812,917 | 33,759 | -6% |
| BlackSky TechnologyBKSY | 0.6% | $802,700 | 28,750 | Held |
| AppleAAPL | 0.6% | $766,804 | 2,650 | Held |
| Profound MedicalPROF | 0.6% | $759,962 | 114,280 | Held |
| US BancorpUSB | 0.6% | $745,940 | 12,350 | Held |
| Neuroone Medical TechnologiesNMTC | 0.6% | $743,754 | 244,656 | New |
| VIDA GlobalVIDA | 0.5% | $700,000 | 250,000 | New |
| TargetTGT | 0.5% | $620,397 | 4,750 | -3% |
| OwletOWLT | 0.5% | $611,281 | 106,495 | Held |
| Elauwit ConnectionELWT | 0.4% | $597,935 | 55,500 | Held |
| MDxHealth SAMDXH | 0.4% | $579,722 | 1,411,891 | -4% |
| Seagate Technology HoldingsSTX | 0.4% | $506,625 | 525 | -5% |
| AtriCureATRC | 0.4% | $489,650 | 17,500 | -33% |
| ConocoPhillipsCOP | 0.4% | $483,414 | 4,650 | -4% |
| NXP SemiconductorsNXPI | 0.4% | $477,751 | 1,700 | -6% |
| LifevantageLFVN | 0.4% | $470,858 | 75,458 | Held |
| CelcuityCELC | 0.4% | $470,790 | 4,500 | -17% |
| General MillsGIS | 0.3% | $434,350 | 8,375 | -6% |
| SkyWater TechnologySKYT | 0.3% | $414,358 | 11,900 | -55% |
| Bristol-Myers SquibbBMY | 0.3% | $413,712 | 7,180 | -3% |
| DonaldsonDCI | 0.3% | $412,942 | 4,600 | Held |
| QT Imaging HoldingsQTI | 0.3% | $407,000 | 100,000 | New |
| Verizon CommunicationsVZ | 0.3% | $385,633 | 9,108 | Held |
| Castle BiosciencesCSTL | 0.3% | $384,939 | 16,140 | +5% |
| ElutiaELUT | 0.3% | $379,934 | 694,094 | -8% |
| FastenalFAST | 0.3% | $348,217 | 7,250 | Held |
| AT&TT | 0.2% | $331,034 | 15,992 | Held |
| BPBP | 0.2% | $319,617 | 8,650 | -6% |
| Johnson & JohnsonJNJ | 0.2% | $304,764 | 1,200 | Held |
| Beeline HoldingsBLNE | 0.2% | $290,360 | 238,000 | -3% |
| ModernaMRNA | 0.2% | $280,120 | 4,000 | Held |
| ExagenXGN | 0.2% | $264,101 | 56,796 | -21% |
| Apyx MedicalAPYX | 0.1% | $188,580 | 42,000 | Held |
| AirgainAIRG | 0.1% | $138,600 | 22,000 | Held |
| Puma BiotechnologyPBYI | <0.1% | $108,674 | 13,400 | +7% |
| OptimizeRxOPRX | <0.1% | $84,702 | 14,808 | -7% |
| IridexIRIX | <0.1% | $81,066 | 70,800 | +28% |
| Perspective TherapeuticsCATX | <0.1% | $62,062 | 18,200 | New |
| SOPHiA GENETICS SASOPH | <0.1% | $60,585 | 10,500 | Held |
| PulmonxLUNG | <0.1% | $51,350 | 39,500 | -4% |
| Dyadic InternationalDYAI | <0.1% | $43,053 | 48,050 | Held |
| AccurayARAY | <0.1% | $5,156 | 20,000 | -62% |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 33.7% since 30 June 2025.
Where the money is
Health care55.3%
Technology31.0%
Media & telecom7.1%
Industrials2.2%
Financial services2.1%
Materials0.9%
Everyday goods0.8%
Energy0.6%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.